Arrowhead Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 2.75%309.790.0%$5214.82m
BNTXBioNTech SE 2.65%342.310.0%$1573.28m
NVAXNovavax, Inc. -1.57%159.4278.2%$844.03m
AMGNAmgen, Inc. 0.43%202.041.4%$595.81m
GILDGilead Sciences, Inc. -0.34%69.431.0%$508.03m
VRTXVertex Pharmaceuticals, Inc. -0.95%202.511.9%$474.46m
REGNRegeneron Pharmaceuticals, Inc. -1.35%625.452.7%$467.64m
LGVNLongeveron Inc. 16.11%20.900.0%$416.81m
ILMNIllumina, Inc. -3.49%345.013.3%$313.91m
SNSSSunesis Pharmaceuticals, Inc. -3.74%4.120.7%$288.00m
BIIBBiogen, Inc. -2.80%222.111.8%$271.16m
OCGNOcugen, Inc. -9.27%5.730.0%$192.28m
INCYIncyte Corp. -1.88%65.382.4%$153.30m
EXASEXACT Sciences Corp. -5.55%76.1018.0%$147.39m
SGENSeagen Inc. -5.56%149.855.8%$142.97m

Company Profile

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.